Hippophate flavone powder capsule and its preparing method

A seabuckthorn flavone and soft capsule technology, which is applied in the directions of capsule delivery, pharmaceutical formulations, and medical preparations containing active ingredients, can solve problems such as the increase in the prevalence of cardiovascular and cerebrovascular diseases, improve blood rheology, and inhibit platelet aggregation. , Improve the effect of myocardial circulation
CN101023969AInactive Publication Date: 2007-08-29XINMA MEDICINE SCI TECH SHENYANG

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
XINMA MEDICINE SCI TECH SHENYANG
Publication Date
2007-08-29
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention discloses a hippophae rhmnoides flavone soft capsule and its preparation method. The invented hippophae rhmnoides flavone soft capsule is formed from two portions of content material and capsule shell. Its content material is composed of hippophae rhmnoides flavone, vegetable oil and bee's wax, and its capsule shell is made up by using gelatin, water, glycerine and preserving agent. Said hippophae rhmnoides flavone soft capsule can obtain good therapeutic effect for curing the diseases of hypertension, hyperlipemia, coronary heart disease and other angiocardipathy and cerebrovascular disease.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention relates to a pharmaceutical preparation of seabuckthorn flavonoids, more specifically to a seabuckthorn flavonoid soft capsule, and simultaneously the invention also relates to a preparation method of the preparation. Background technique

[0002] Cardiovascular disease and cerebrovascular disease are recognized as two major enemies that endanger human health and survival. According to national statistics in 1996, cardiovascular disease (CVD) caused about 15.5 million deaths, accounting for 30% of the global death toll due to disease in that year. %. It accounts for 45.6% of the total deaths in developed countries and 24.5% of the total deaths in developing countries. Among the main causes of death due to diseases, coronary heart disease and cerebrovascular disease ranked first and second respectively with 7.2 million and 4.6 million people in 1996. Experts pointed out that smoking, hyperlipidemia, high blood pressure, abnormal blood su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More